Ms. Boudreau is a retired senior executive with a 30-year career in the biotech, pharmaceuticals, consulting and banking industries. Most recently, she served as Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute. Over the course of her career, Ms. Boudreau held positions of increasing scope and responsibility in finance in the biotech and pharmaceutical industries, including roles as Chief Financial Officer for Proteostasis Therapeutics (NASDAQ: PTI), Chief Financial Officer for FORMA Therapeutics, Chief Financial Officer for Novartis Corporation in the U.S., global Chief Financial Officer for Novartis Oncology and senior finance positions at Pfizer, Inc. She currently serves on the Board of Premier Inc. (NASDAQ: PINC), a healthcare improvement company, and three private biotechnology companies. She previously served on the board of Proteostasis Therapeutics, Inc. (NASDAQ: PTI), and was Chair of the Audit Committee. Ms. Boudreau received a BA in Economics from the University of Maryland, and an MBA from the Darden Graduate School of Business Administration, University of Virginia.

Ms. Boudreau is the Chair of the Audit Committee at Rallybio.